add share buttons

Botulinum Toxin for Migraines

Collars have a huge number of possible causes and are among the very debilitating common ailments that attract patients to primary care physicians and neurologists. Migraine headaches affect about 29.5 million men and women in America. Get to know more about botulinum toxin via clinique-suisse.com/en/medicine-and-cosmetic-surgery/cosmetic-medicine/botulinum-toxin.

Women are 3 times more likely to have problems with them than men. They're more widespread among individuals between 20 and 45 years old and are the main cause of work absenteeism and decreased work productivity. The indirect and direct cost of migraines into the market is estimated at $50 billion annually.

Employing botulinum toxin injections is a contentious remedy to avoid migraine headaches. Reports from the scientific literature (such as retrospective case series ( uncontrolled and no blinded studies, little controlled trials and case reports) indicate botulinum reduces migraines in some patients.

But recently several bigger and randomized, double-blind, placebo-controlled clinical trials which were otherwise designed don´t prefer botulinum toxin as a therapy. A clinical trial entitled “A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients using Regular Headaches" is now underway.

Now some clinicians use botulinum toxin injections hoping to handle patients who have frequent and severe migraines. Given that the varying clinical encounters reported, among the standards suggested for physicians to pick patients for this therapy is their inability to react to other migraine remedies; but every migraine sufferer is exceptional.

Doctors contemplating botulinum toxin treatment to get a migraine patient must have a comprehensive review of this patient´s medical background; conduct an in-depth physical exam; execute or examine diagnostic studies; contemplate past and present treatments and the patient´s answers to them, and think about any co-morbid disorders or ailments.